A novel ZMP analog 3 was synthesized from inosine in 10 steps, and exhibited small but significant inhibitory activity toward protein kinase C.
5-Amino-1--D-ribofuranosylimidazole-4-carboxamide (AICAR; 1) is a constituent of AICA-ribotide (ZMP 2), which is a biosynthetic precursor of purine nucleotide (AMP, GMP). Recently AICAR 1 has been receiving great clinical attention since it is an activator of AMPactivated protein kinase (AMPK). [1] [2] [3] [4] [5] AICAR 1 is converted to ZMP 2 within cells, and this activates AMPK by mimicking the effect of AMP. ZMP analog is expected to have more potent activity than AICAR 1 toward AMPK and to be a useful tool for clarifying the mechanism of AMPK activation. In this context, we designed the ZMP analog 3, in which the 5 0 -oxygen atom of ZMP 2 is replaced by a CH 2 group (Fig. 1) .
We started the synthesis of 3 from inosine based on our experience of syntheses of AICAR and its derivatives. 6, 7) MEM-Protected inosine 4 was obtained from inosine through a three-step transformation according to the proceeding report.
6) Treatment of 4 with 2,2-dimethoxypropane and p-toluenesulfonic acid gave isopropylidene derivative 5 in 89% yield. The Moffatt oxidation of the primary hydroxy group of 5 followed by the Wittig reaction with 6 8) gave unsaturated phosphonic acid derivative 7 in 40% yield from 5.
We carried out the reduction of 7 by diimide 9) generated in situ from o-nitrobenzenesulfonylhydrazide, 10) because the catalytic hydrogenation of 7 with Pd/C was very sluggish. Treatment of 7 with o-nitrobenzenesulfonylhydrazide and excess Et 3 N gave saturated phosphonic acid derivative 8 in a quantitative yield.
11) The acidic cleavage of the isopropylidene group of 8 with Dowex 50w (H þ ) in MeOH gave 9 in 79% yield.
12) The ring-opening reaction of 9 with 0.2 M NaOH followed by ion exchange chromatography with Dowex 50w (H þ ) gave mono-ester 10 in 82% yield. Treatment of 10 with bromotrimethylsilane (TMSBr) followed by hydrolysis gave the novel ZMP analog 3 in 21% yield (Scheme 1).
Since it has been reported that activation of protein kinase C (PKC) correlates with the pathogenesis of diabetic retinopathy and that activation can be a possible therapeutic target of this disease, 13) we first tested the inhibitory activity of 3 toward PKC. AICAR 1 did not show any inhibitory activity toward PKC isolated from the v-src transformant of NIH3T3 cell. On the other hand, 3 showed weak but significant inhibitory activity (50-80% inhibition at 0.3 mM) toward PKC. These results suggest that ZMP analog 3 can be a useful tool for clarifying the mechanism of AMPK activation in the cell. Assay of 3 and related compounds toward AMPK is now under way, and the results will be reported elsewhere.
Experimental

General.
1 H and 13 C NMR were recorded with an JEOL-JNM-EX-270 (at 270 MHz to 1 H, 68 MHz to 13 C) or alpha-500 (at 500 MHz to 1 H, 126 MHz to 13 C). Optical rotation was measured with a JASCO DIP-1000 (with a 1 dm cell). HR-FAB-MAS analyses were done with a JEOL JMS-DX-300. TLC analyses were performed on Silica gel 60-F254 (Merck). Column chromatography was performed on silica gel (Wako Pure Chemical Industries, Wakogel C-300).
. A solution of 4 (4.51 g, 12.5 mmol) and 2,2-dimethoxypropane 3 ). Thus obtained 5 was used for the next step without further purification. To a solution of 5 (2.00 g, 5.05 mmol) in DMSO (10 ml) and CH 2 Cl 2 (5 ml) were added pyridinium trifluoroacetic acid (487 mg, 2.52 mmol) and then DCC (3.12 g, 15.1 mmol) in CH 2 Cl 2 (10 ml) at room temperature. The reaction mixture was stirred for 5.5 h at the same temperature. To this reaction mixture was added Wittig reagent 6 8) (3.12 g, 7.57 mmol) in CH 2 Cl 2 (10 ml) at room temperature. The reaction mixture was stirred for 16 h at 70 C, cooled to room temperature, and diluted with AcOEt (100 ml). Precipitated 1,3-dicyclohexylurea was removed by filtration. The filtrate was washed with water, dried over MgSO 4 , filtered, and concentrated in vacuo. Purification by column chromatography (silica gel; CHCl 3 -MeOH, 20:1) gave 7 as a pale yellow oil (827 mg, 40% from 1-(2-Methoxy-ethoxymethyl)-9-[5,6-dideoxy-6-(diethoxyphosphinyl)-2,3-O-isopropylidene--D-ribo-hexofuranosyl]-1,9-dihydro-purin-6-one (8) . To a solution of 7 (743 mg, 1.41 mmol) in CH 2 Cl 2 (14 ml) were added o-nitrobenzenesulfonylhydrazide 10) (1.53 g, 7.03 mmol) and Et 3 N (19.6 ml, 14.1 mmol) at room temperature. The reaction mixture was stirred for 19 h at the same temperature and then poured into sat. NaHCO 3 solution. The phases were separated and the aqueous layer was extracted with CHCl 3 (3 Â 15 ml). The combined organic layers were dried over MgSO 4 , filtered, and concentrated in vacuo. Purification by column chromatography (silica gel; CHCl 3 -MeOH, 9:1) gave 8 as a pale yellow oil (745 mg, quant To a solution of 8 (1.80 g, 3 .39 mmol) in MeOH (34 ml) was added Dowex 50w (H þ ) (3.60 g, prewashed with water and MeOH) at room temperature. The reaction mixture was stirred for 1 h at 50 C and filtered, and the filtrate was concentrated in vacuo to give 9 as a colorless oil (1.31 g, 79%). Thus obtained 9 was used for the next step without further purification. A stirred mixture of 9 (1.30 g, 2.65 mmol) and 0.2 M NaOH (79 ml) was heated under reflux for 4.5 h. After cooling, the reaction mixture was neutralized with 6 M HCl, and then concentrated in vacuo. The residue was extracted with hot EtOH (53 ml), and the solution was filtered and concentrated in vacuo. 5-Amino-1-(5,6-dideoxy-6-phosphono--D-ribo-hexofuranosyl)-1H-imidazole-4-carboxamide (3). A solution of 10 (780 mg, 2.14 mmol) in DMF (43 ml) was treated with TMSBr (5.73 ml, 43 mmol) at room temperature. The reaction mixture was stirred for 3 h at the same temperature and then concentrated in vacuo. A mixture of water (6.6 ml) and MeOH (15.4 ml) was added to the residue at room temperature. The reaction mixture was stirred for 45 min and concentrated in vacuo. Purification by ion exchange chromatography (Dowex 50w (H þ ); MeOH, water, and then 28% aq NH 3 ) followed by ion exchange chromatography (Amberlite IRA 96SB; water, and then 0. 
